Carmignac Gestion

Position in NBIX — Neurocrine Biosciences Inc

CIK 1569758 PARIS, I0

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$36,084,414

+$11,580,774 QoQ

Shares Held

214,100

+15.1% QoQ

Ownership

0.211%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

#80

of 772 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Carmignac Gestion holds $297,984,910 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	1,340,100	$148,670,694
2	ZTS	Zoetis Inc.	1,575,700	$113,229,802
3	NBIX	Neurocrine Biosciences Inc This page	214,100	$36,084,414
4			1,659,399	$0

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$36,084,414	214,100	+15.1%	Shares	Sole	2026-08-13
2026-03-31	$24,503,640	186,000	+192.5%	Shares	Sole	2026-06-15
2025-12-31	$9,020,388	63,600	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.